Table 1 Baseline patient characteristics
|  | OSA (N = 373) | non-OSA (N = 379) | P value |
|---|---|---|---|
Age, years (mean ± SD) | 57.6 ± 10.4 | 56.8 ± 10.0 | 0.299 |
Male, n (%) | 315, 84.5% | 306, 80.7% | 0.211 |
BMI | 27.6 ± 3.4 | 25.8 ± 3.3 | < 0.001 |
AHI | 33.7 ± 15.1 | 7.1 ± 4.0 | < 0.001 |
bSS | 14.9 ± 11.0 | 14.4 ± 11.8 | 0.350 |
rSS | 7.8 ± 8.3 | 7.4 ± 9.1 | 0.054 |
Hypertension requiring medication, n (%) | 255, 68.4% | 239, 63.1% | 0.144 |
Hyper cholesterolemia requiring medication, n (%) | 103, 27.6% | 98, 25.9% | 0.621 |
Diabetes mellitus requiring medication, n (%) | 112, 30% | 118, 31.1% | 0.752 |
Myocardial infarction history, n (%) | 57, 15.3% | 52, 13.7% | 0.605 |
Cardiac Intervention history, n (%) | 78, 20.9% | 54, 14.2% | 0.017 |
Time to last cardiac intervention, (days) | 57 ± 49.6 | 67 ± 75 | 0.837 |
 Current smokers, n (%) | 237, 63.5% | 247, 65.2% | 0.649 |
 Family history of CAD, n (%) | 31, 8.3% | 26, 6.9% | 0.492 |
 Minimal SO2, % | 86.4 ± 4.5 | 79.4 ± 8.6 | < 0.001 |
 Mean SO2, % | 93.0 ± 2.3 | 94.6 ± 1.7 | < 0.001 |
 ODI | 33.1 ± 16.1 | 7.9 ± 5.2 | < 0.001 |
Clinical presentation | Â | Â | 0.523 |
 STEMI, n (%) | 124, 33.2% | 119, 31.4% |  |
 NSTEMI, n (%) | 87, 23.3% | 102, 26.9% |  |
 Unstable Angina Pectoris, n (%) | 162, 43.4% | 158, 41.7% |  |
LVEF,% | 59.5 ± 7.7 | 59.8 ± 8.0 | 0.605 |
Post-procedural medication, n (%) | |||
 ACE inhibitors or ARB | 271, 72.7% | 258, 68.1% | 0.175 |
 Beta-blockers | 290, 77.7% | 284, 74.9% | 0.391 |
Antiplatelet therapy | |||
 Aspirin | 354, 94.9% | 354, 93.4% | 0.438 |
 P2Y12 inhibitor | 342, 91.7% | 331, 87.3% | 0.057 |
 Statin | 357, 95.7% | 356, 93.9% | 0.324 |
Anatomical characteristics | |||
 Multi-vessel disease, n (%) |  |  | 0.024 |
  Three vessel disease, n (%) | 102, 27.3% | 86, 22.7% |  |
  Two vessel disease, n (%) | 143, 38.3% | 122, 32.2% |  |
Left main disease, n (%) | 12, 3.2% | 17, 4.5% | 0.45 |
Any total occlusions | 88, 23.6% | 58, 15.3% | 0.004 |
Any bifurcation | 210, 61.4% | 198, 58.8% | 0.764 |
Any aorta-ostial lesion | |||
 Diffuse disease | |||
  Any lesion > 20 mm | 90, 24.1% | 78, 20.6% | 0.256 |
  Any severe calcification | 29, 7.8% | 41, 10.8% | 0.168 |
  Any severe tortuosity | 32, 8.6% | 22, 5.8% | 0.159 |
  Any angiographically visible thrombus | 53, 14.2% | 63, 16.6% | 0.366 |
Procedure related characteristics | |||
 CABG, n (%) | 34, 9.1% | 41, 10.8% | 0.467 |
 PCI, n (%) | 58.7% | 51.7% | 0.057 |
 Total number of stent, n | 1.0 ± 1.0 | 0.8 ± 1.0 | 0.046 |
 Hospital stay, n | 4.9 ± 2.9 | 4.7 ± 2.9 | 0.371 |